IMRT in hypopharyngeal tumors

Strahlentherapie und Onkologie

Volumn 182, Issue 6, 2006, Pages 331-335

  Studer, Gabriela ^a   Lütolf, Urs Martin ^b   Davis, Jacques Bernard ^b   Glanzmann, Christoph ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Universitätsspital Zürich ^*

Author keywords

Hypopharyngeal cancer; IMRT; Radiation related dysphagia; SIB

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SIZE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DYSPHAGIA; FEMALE; FIBROSIS; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; LARYNGECTOMY; LARYNX DISORDER; MALE; PATIENT SATISFACTION; RADIATION DOSE; SIMULTANEOUS INTEGRATED BOOST INTENSITY MODULATED RADIATION THERAPY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DEGLUTITION DISORDERS; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33646558620     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1556-2     Document Type: Article

References (30)

1. Altundag O, Gullu I, Altundag K, et al. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Head Neck 2005;27:15-21.
2. Bahadur S, Thakar A, Mohanti BK, et al. Results of radiotherapy with, or without, salvage surgery versus combined surgery and radiotherapy in advanced carcinoma of the hypopharynx. J Laryngol Otol 2002;116:29-32.
3. Chu PY, Wang LW, Chang SY. Surgical treatment of squamous cell carcinoma of the hypopharynx: analysis of treatment results, failure patterns, and prognostic factors. J Laryngol Otol 2004;118:443-9.
4. During A, Sauer R, Steiner W, et al. [Combined treatment of hypopharyngeal carcinoma.] Strahlenther Onkol 1987;163:764-73.
5. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004;59:28-42.
6. Featherstone CJ, Clarke S, Jackson MA, et al. Treatment of advanced cancer of the larynx and hypopharynx with chemoradiation. Aust N Z J Surg 2004;74:554-8.
7. Fein DA, Mendenhall WM, Parsons JT, et al. Pharyngeal wall carcinoma treated with radiotherapy: impact of treatment technique and fractionation. Int J Radiat Oncol Biol Phys 1993;26:751-7.
8. Garden AS, Morrison WH, Clayman GL, et al. Early squamous cell carcinoma of the hypopharynx: outcomes of treatment with radiation alone to the primary disease. Head Neck 1996;18:317-22.
9. Godballe C, Jorgensen K, Hansen O, et al. Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery. Laryngoscope 2002;112:834-8.
10. Grosu AL, Piert M, Weber WA, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005;181:483-99.
11. Hamoir M, Ledeghen S, Rombaux P, et al. Conservation surgery for laryngeal and hypopharyngeal cancer. Acta Otorhinolaryngol Belg 1999;53:207-13.
12. Huguenin P, Beer KT, Allal A, et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 2004;22:4665-73.
13. Johansen LV, Grau C, Overgaard J. Hypopharyngeal squamous cell carcinoma - treatment results in 138 consecutively admitted patients. Acta Oncol 2000;39:529-36.
14. Johansson J, Blomquist E, Montelius A, et al. Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma. Radiother Oncol 2004;72:129-38.
15. Kim S, Wu HG, Heo DS, et al. Advanced hypopharyngeal carcinoma treatment results according to treatment modalities. Head Neck 2001;23:713-7.
16. Kuhnt T, Jirsak N, Muller AC, et al. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer.] Strahlenther Onkol 2005;181:520-8.
17. Kurek R, Kalogera-Fountzila A, Muskalla K, et al. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strahlenther Onkol 2003;179:292-7.
18. Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005;115:629-39.
19. Lefebvre JL. Larynx preservation: the discussion is not closed. Otolaryngol Head Neck Surg 1998;118:389-93.
20. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996;88:890-9.
21. Luukkaa M, Minn H, Aitasalo K, et al. Treatment of squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx - an analysis of 174 patients in south western Finland. Acta Oncol 2003;42:756-62.
22. Momm F, Volegova-Neher NJ, Schulte-Monting J, et al. Different saliva substitutes for treatment of xerostomia following radiotherapy. A prospective crossover study. Strahlenther Onkol 2005;181:231-6.
23. Nakamura K, Shioyama Y, Sasaki T, et al. Chemoradiation therapy with or without salvage surgery for early squamous cell carcinoma of the hypopharynx. Int J Radiat Oncol Biol Phys 2005;62:680-3.
24. Rudert HH, Hoft S. Transoral carbon-dioxide laser resection of hypopharyngeal carcinoma. Eur Arch Otorhinolaryngol 2003;260:198-206.
25. Salz H, Wiezorek T, Scheithauer M, et al. IMRT with compensators for head-and-neck cancers. Treatment technique, dosimetric accuracy, and practical experiences. Strahlenther Onkol 2005;181:665-72.
26. Samant S, Kumar P, Wan J, et al. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: disease control and preservation of organ function. Head Neck 1999;21:595-601.
27. Stuschke M, Budach V, Dinges S, et al. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas.] Strahlenther Onkol 1994;170:689-99.
28. Urba SG, Wolf GT, Bradford CR, et al. Neoadjuvant therapy for organ preservation in head and neck cancer. Laryngoscope 2000;110:2074-80.
29. Wiggenraad R, Mast M, van Santvoort J, et al. ConPas: a 3-D conformal parotid gland-sparing irradiation technique for bilateral neck treatment as an alternative to IMRT. Strahlenther Onkol 2005;181:673-82.
30. Zelefsky MJ, Kraus DH, Pfister DG, et al. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck 1996;18:405-11.